Chiome Bioscience Inc (4583) Stock Price & News

4583:TYO

Chiome Bioscience Inc

¥85.00

-1.16%

(-1.00) 1D

Nov 4, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4583...

Open

¥86

High

¥86

Low

¥82

Mkt. cap

6.96B

Avg. vol.

1.02M

Volume

752.90K

52-wk high

¥136

52-wk low

¥65

EPS

-¥13

Shares outstanding

26.78M

No. of employees

Open

¥86

High

¥86

Low

¥82

Mkt. cap

6.96B

Avg. vol.

1.02M

Volume

752.90K

52-wk high

¥136

52-wk low

¥65

EPS

-¥13

Shares outstanding

26.78M

No. of employees

Related stocks

D.Western Therapeutics Institute Inc

News stories

From web sources and news partners

FinancialContent

24 minutes ago

U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

MarketWatch

1 hour ago

Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress

shattered.io

31 minutes ago

S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]

PBS

1 hour ago

U.S. stocks surge, and the Dow soars 1,500 points as Brent oil's price drops below $95 per barrel

About Chiome Bioscience Inc

CEO-

Employees49

FoundedFeb 8, 2005

Headquarters-

SectorHealth care

Industry-

Websitechiome.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	118.02M	223.48M	147.16M	126.50M
Cost of goods sold	52.72M	72.06M	66.64M	48.50M
Cost of revenue	52.72M	72.06M	66.64M	48.50M
Research and development expenses	190.33M	190.34M	174.47M	194.51M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	143.50M	135.51M	138.40M	130.86M
Operating expense	333.83M	325.84M	312.87M	325.37M
Total operating expenses	386.54M	397.90M	379.51M	373.87M
Operating income	-268.52M	-174.43M	-232.34M	-247.37M
Other non operating income	-109.00K	-7.02M	-980.00K	-1.76M
EBT including unusual items	-259.15M	-181.72M	-232.34M	-249.28M
EBT excluding unusual items	-268.39M	-181.72M	-232.34M	-249.28M
Income tax expense	810.00K	810.00K	810.00K	810.00K
Effective tax rate	-0.31%	-0.45%	-0.35%	-0.32%
Other operating expenses	-	-	-	-
Net income	-259.96M	-182.53M	-233.15M	-250.09M
Net profit margin	-220.27%	-81.68%	-158.43%	-197.71%
Earnings per share	-	-	-	-
Interest and investment income	1.42M	126.00K	1.03M	123.00K
Interest expense	-959.00K	-256.00K	-292.00K	-313.00K
Net interest expenses	463.00K	-130.00K	739.00K	-190.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-268.23M	-173.49M	-231.41M	-244.96M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything